Evaluation of Functional and Morphological Retinal Changes in the Course of Systemic Aranesp Treatment in Patients With Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2015
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms EPOinDR
- 23 Sep 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Sep 2009 Planned end date changed from 1 May 2010 to 1 Sep 2009 as reported by ClinicalTrials.gov.
- 22 Jul 2008 New trial record.